| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2282784
Max Phase: Preclinical
Molecular Formula: C21H32N2O3
Molecular Weight: 360.50
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CON(C)C(=O)[C@H]1CC[C@H]2[C@@H]3CNC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
Standard InChI: InChI=1S/C21H32N2O3/c1-20-10-8-16-14(12-22-18-11-13(24)7-9-21(16,18)2)15(20)5-6-17(20)19(25)23(3)26-4/h11,14-17,22H,5-10,12H2,1-4H3/t14-,15-,16-,17+,20-,21+/m0/s1
Standard InChI Key: KCOSTVZZMPPIOT-XYNCURNNSA-N
Associated Targets(Human)
Steroid 5-alpha-reductase 2 937 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 360.50 | Molecular Weight (Monoisotopic): 360.2413 | AlogP: 2.92 | #Rotatable Bonds: 2 |
| Polar Surface Area: 58.64 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.12 | CX LogD: 2.12 |
| Aromatic Rings: 0 | Heavy Atoms: 26 | QED Weighted: 0.77 | Np Likeness Score: 1.23 |
References
| 1. Kumar R, Kumar M. (2013) 3D-QSAR CoMFA and CoMSIA studies for design of potent human steroid 5-reductase inhibitors, 22 (1): [10.1007/s00044-012-0006-1] |
Source
Source(1):